Volhoubare fasiliteitsbestuur in winkelsentrums in Pretoria

Although sustainable facility management is increasingly gaining recognition in developing countries and is implemented in new buildings, in particular, hardly any information is available regarding sustainable practices in facility management that are applied locally in South Africa, and particularly in Pretoria. In this article, five key areas for sustainable facility management in shopping centres are investigated, namely energy consumption, water consumption, materials and resource management, internal environment quality management, and location management. This study also established which sustainable facility management strategies and methods are currently being applied and what perceptions property managers in shopping centres in Pretoria have regarding sustainable facility management. Questionnaires and one-on-one interviews with property managers and centre managers and owners were employed to obtain qualitative information such as the perceptions and knowledge of the respondents, as well as quantitative information such as quantities and percentages. The sample and data collected for the study are limited to shopping malls in Pretoria with a commercial area of 10 000m² or more, which yielded a total of 69 shopping centres. Completed questionnaires were returned by approximately a quarter of the total sample population, representing a lettable area of 765 835m2 and 1 663 stores. Nearly 90% of the respondents indicated that the ‘property’ management function is done internally, compared with over 94% that internally manage the ‘facility’ management function. It was found that sustainable facility management practices are being applied in shopping centres in Pretoria, but that there is a clear preference for widely applied practices that lead to financial savings. Practices that contribute to social and environmental objectives are applied to a much lesser extent, due to the perception that such practices do not result in financial savings or contribute to the management of the centres and are, therefore, regarded as less important. *This article is written in Afrikaans

FAST Heroes : Results of Cross-Country Implementation of a Global School-Based Stroke Education Campaign

Funding Information: This study received funding from Boehringer Ingelheim (Grant Number 395479, 2019). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. Publisher Copyright: Copyright © 2022 Tsakpounidou, van der Merwe, Klinke, Webb, Ouriques Martins and Proios.Background: Educating the at-risk population about stroke symptoms and requirement of calling an ambulance when stroke strikes is challenging. This exploratory cross-country study provides insights to the FAST Heroes educational campaign and outcomes hitherto achieved. Aims: The primary aim of the study was to measure the transfer of stroke-related knowledge to parents after a global school-based FAST Heroes educational campaign for 5- to 9-year-old children in 14 different countries. The secondary aim was to evaluate parents and teachers' acceptability toward the program. Methods: The duration of the program was 5 h; 1 h per week, joining face-to-face educational sessions with workbooks, cartoons, web-based learning, and other fun activities. Outcomes were measured before implementation (t1), after implementation (t2), and at 6-month follow-up (t3). Program acceptability and stroke knowledge were evaluated by feedback surveys for teachers and parents. Results: Worldwide, 4,202 parents completed the program with their children and answered surveys at t1 and t2. They increased their knowledge of three stroke symptoms from 48 to 83% (p < 0.001). All three surveys were completed by 86 parents, who improved their knowledge of stroke symptoms, 55% (t1), 79% (t2), and 94% (t3) (p < 0.001). Overall, the educational messages were successfully passed onward. Conclusions: Findings confirm the primary aim of the study that is knowledge about stroke transfer well from children to their families through the FAST Heroes program. Second, parents and teachers globally consider the program feasible and worthwhile. The results will inform further rollout of the campaign.Peer reviewe

A Panel of Ancestry Informative Markers for the Complex Five-Way Admixed South African Coloured Population

Admixture is a well known confounder in genetic association studies. If genome-wide data is not available, as would be the case for candidate gene studies, ancestry informative markers (AIMs) are required in order to adjust for admixture. The predominant population group in the Western Cape, South Africa, is the admixed group known as the South African Coloured (SAC). A small set of AIMs that is optimized to distinguish between the five source populations of this population (African San, African non-San, European, South Asian, and East Asian) will enable researchers to cost-effectively reduce false-positive findings resulting from ignoring admixture in genetic association studies of the population. Using genome-wide data to find SNPs with large allele frequency differences between the source populations of the SAC, as quantified by Rosenberg et. al's -statistic, we developed a panel of AIMs by experimenting with various selection strategies. Subsets of different sizes were evaluated by measuring the correlation between ancestry proportions estimated by each AIM subset with ancestry proportions estimated using genome-wide data. We show that a panel of 96 AIMs can be used to assess ancestry proportions and to adjust for the confounding effect of the complex five-way admixture that occurred in the South African Coloured population.Department of HE and Training approved lis

Rituximab and improved nodular regenerative hyperplasia-associated non-cirrhotic liver disease in common variable immunodeficiency: a case report and literature study

Common variable immunodeficiency (CVID) associated liver disease is an underrecognized and poorly studied non-infectious complication that lacks an established treatment. We describe a CVID patient with severe multiorgan complications, including non-cirrhotic portal hypertension secondary to nodular regenerative hyperplasia leading to diuretic-refractory ascites. Remarkably, treatment with rituximab, administered for concomitant immune thrombocytopenia, resulted in the complete and sustained resolution of portal hypertension and ascites. Our case, complemented with a literature review, suggests a beneficial effect of rituximab that warrants further research

Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial

Obesity is a frequent complication following liver transplantation and is insufficiently responsive to dietary and life style advice. We studied the safety of orlistat treatment in obese and overweight liver transplant recipients (n = 15) on a stable tacrolimus-based immunosuppressive regimen. For safety reasons, the treatment period was restricted (6 months 120 mg t.i.d., 3 months 120 mg daily). Three patients dropped out, tacrolimus dose was adjusted in six of 12 remaining patients (dose reduction in 4, increase in 2, P = N.S.). All dose adjustments occurred during the 6 months of orlistat 120 mg t.i.d. therapy. No drug intolerance, adverse events or episodes of rejection occurred during the study. Efficacy of orlistat treatment in this population could not be shown, because a formal control population was not included in this safety trial. Moreover, only a significant decrease of waist circumference (P < 0.01 versus start of the study), but not of weight or body mass index, was achieved in the treated group. Orlistat treatment is well tolerated in liver transplant recipients and can be started safely, provided immunosuppressive drug levels and dietary adherence are closely monitored

In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling

<p>Abstract</p> <p>Background</p> <p>Anti-malarial drug resistance threatens to undermine efforts to eliminate this deadly disease. The resulting omnipresent requirement for drugs with novel modes of action prompted a national consortium initiative to discover new anti-plasmodial agents from South African medicinal plants. One of the plants selected for investigation was <it>Dicoma anomala </it>subsp. <it>gerrardii</it>, based on its ethnomedicinal profile.</p> <p>Methods</p> <p>Standard phytochemical analysis techniques, including solvent-solvent extraction, thin-layer- and column chromatography, were used to isolate the main active constituent of <it>Dicoma anomala </it>subsp. <it>gerrardii</it>. The crystallized pure compound was identified using nuclear magnetic resonance spectroscopy, mass spectrometry and X-ray crystallography. The compound was tested <it>in vitro </it>on <it>Plasmodium falciparum </it>cultures using the parasite lactate dehydrogenase (pLDH) assay and was found to have anti-malarial activity. To determine the functional groups responsible for the activity, a small collection of synthetic analogues was generated - the aim being to vary features proposed as likely to be related to the anti-malarial activity and to quantify the effect of the modifications <it>in vitro </it>using the pLDH assay. The effects of the pure compound on the <it>P. falciparum </it>transcriptome were subsequently investigated by treating ring-stage parasites (alongside untreated controls), followed by oligonucleotide microarray- and data analysis.</p> <p>Results</p> <p>The main active constituent was identified as dehydrobrachylaenolide, a eudesmanolide-type sesquiterpene lactone. The compound demonstrated an <it>in vitro </it>IC₅₀of 1.865 μM against a chloroquine-sensitive strain (D10) of <it>P. falciparum</it>. Synthetic analogues of the compound confirmed an absolute requirement that the α-methylene lactone be present in the eudesmanolide before significant anti-malarial activity was observed. This feature is absent in the artemisinins and suggests a different mode of action. Microarray data analysis identified 572 unique genes that were differentially expressed as a result of the treatment and gene ontology analysis identified various biological processes and molecular functions that were significantly affected. Comparison of the dehydrobrachylaenolide treatment transcriptional dataset with a published artesunate (also a sesquiterpene lactone) dataset revealed little overlap. These results strengthen the notion that the isolated compound and the artemisinins have differentiated modes of action.</p> <p>Conclusions</p> <p>The novel mode of action of dehydrobrachylaenolide, detected during these studies, will play an ongoing role in advancing anti-plasmodial drug discovery efforts.</p

Resensies

Book Review 1Book Title: Skollie: One man’s struggle to survive by telling storiesBook Author: John W. FredericksCape Town: Penguin Random House. 251 pp. ISBN: 978-1-77609-199-7.Book Review 2Book Title: A Gap in the HedgeBook Author: Johan Vlok LouwCape Town: Umuzi, 2017. 233 pp. ISBN: 978-1-4152-08915Book Review 3Book Title: Iziganeko zesizwe: Occasional Poems (1900–1943)Book Authors: S.E.K. Mqhayi. Eds. and trans. Jeff Opland and Peter T. MtuzePietermaritzburg: University of KwaZulu Natal Press, 2017. 469 pp. ISBN: 9781869143343; e-ISBN: 9781869143350.Book Review 4Book Title: Oorlog en terpentynBook Authors: Stefan Hertmans. Vertaal deur Daniel HugoPretoria: Protea Boekhuis, 2016. 335 pp. ISBN: 978-1-4853-0610-8; e-Boek: 978-1-4853-0722-8; Epub: 978-1-4853-0723-5.Book Review 5Book Title: Groen soos die hemel daarboBook Author: Eben VenterKaapstad: Tafelberg, 212 pp. ISBN: 978-0-624-08261-3.Book Review 6Book Title: Die wêreld van Charlie OengBook Author: Etienne van HeerdenKaapstad: Tafelberg, 2017. 559 pp. ISBN 978-0-624-08052-7.Book Review 7Book Title: Die diepblou seeBook Author: François LootsKaapstad: Umuzi, 2017. 239 pp. ISBN: 978-1-4152-0953-0.Book Review 8Book Title: Die derde spoelBook Author: S.J. NaudéKaapstad: Umuzi, 2017. 342 pp. ISBN: 978-1-4152-0747-5 (Druk). ISBN: 978-1-4152-0748-2 (ePub).Book Review 9Book Title: Nou, hierBook Author: Corné CoetzeeKaapstad: Human &amp; Rousseau, 2017. 107 pp. ISBN 978-0-7981-7620-0.Book Review 10Book Title: RadbraakBook Author: Jolyn PhillipsKaapstad: Human &amp; Rousseau, 2017. 68 pp. ISBN: 978-0-7981-7616-3.Book Review 11Book Title: VuurvasBook Author: Carel AntonissenNaledi, 2016. ISBN 978-0-928316-97-1.Book Review 12Book Title: Voor ek my kom kryBook Author: Pirow BekkerPretoria: Protea Boekhuis, 2017. 110 pp. ISBN: 978-1-4853-0648-1.Book Review 13Book Title: Nuwe stemme 6Book Authors: Bibi Slippers en Charl-Pierre Naudé (samenstellers)Kaapstad: Tafelberg, 2017. 176 pp. ISBN 9780624082644.Book Review 14Book Title: UittogboekBook Author: Johan MyburgPretoria: Protea, 2017. 100 pp. ISBN: 9781485307761.Book Review 15Book Title: Krap uit die seeBook Author: Fourie BothaPretoria: Protea Boekehuis, 2017. 64 pp. ISBN 9781485307570.Book Review 16Book Title: Skepelinge. Aanloop tot ‘n romanBook Author: Karel SchoemanKaapstad: Human &amp; Rousseau, 2017. 576 pp. ISBN: 978079817610.Book Review 17Book Title: Die reis gaan inwaarts: Die kuns van sterwe in kreatiewe werke van Karel SchoemanBook Author: Cas WepenerStellenbosch: Sun MeDIA MeTRO. Druknaam: SUN PRESS, 2017. 233 pp. ISBN: 978-1-928355-14-4 (Druk); ISBN: 979-1-928355-15-1 (e-boek)

HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor

HIV-specific cytotoxic T lymphocytes (CTL) are important in controlling HIV replication, but the magnitude of the CTL response does not predict clinical outcome. In four donors with delayed disease progression we identified Vβ13.2 T cell receptors (TCRs) with very similar and unusually long β-chain complementarity determining region 3 (CDR3) regions in CTL specific for the immunodominant human histocompatibility leukocyte antigens (HLA)-B8–restricted human immunodeficiency virus-1 (HIV-1) nef epitope, FLKEKGGL (FL8). CTL expressing Vβ13.2 TCRs tolerate naturally arising viral variants in the FL8 epitope that escape recognition by other CTL. In addition, they expand efficiently in vitro and are resistant to apoptosis, in contrast to FL8–specific CTL using other TCRs. Selection of Vβ13.2 TCRs by some patients early in the FL8-specific CTL response may be linked with better clinical outcome